It is a condition that most commonly affects our young athletes, but many of the symptoms of hypertrophic cardiomyopathy (HCM) do not manifest until it is too late. How are we improving our techniques and strategies for preventing, identifying and addressing HCM before it leads to tragedy? Dr. Theodore Abraham, associate professor of medicine at the Johns Hopkins University School of Medicine, and associate director of the echocardiography laboratory at Johns Hopkins Hospital, joins host Dr. Janet Wright to talk over key issues in our understanding of HCM, including his advice for patients with phenotypically mild disease progression.
